Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects

This publication has 29 references indexed in Scilit:

• Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease
  The American Journal of Cardiology, 2001
• Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality
  Archives of internal medicine (1960), 2001
• Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study
  Atherosclerosis, 2001
• Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease
  Circulation, 1999
• Hypertriglyceridemia, Atherogenic Dyslipidemia, and the Metabolic Syndrome
  The American Journal of Cardiology, 1998
• Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1993
• Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.
  Circulation, 1993
• Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion
  Metabolism, 1993
• Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia
  European Journal of Clinical Investigation, 1989
• Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1987